AI assistant
Sending…
ETHZilla Corp — Director's Dealing 2021
Dec 10, 2021
33039_dirs_2021-12-09_1c5d7fb0-7b23-4938-9976-3ccd9de9280c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-12-09
Reporting Person: McGovern Jr. Donald A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-09 | Common Stock | P | 25000 | $4.13 | Acquired | 32628 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $4.07 to $4.25. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
More from ETHZilla Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 20